Shanghai Yizhong Pharmaceutical (688091.SS) Earnings Analysis
Shanghai Yizhong Pharmaceutical (688091.SS) has no confirmed upcoming earnings date. Trailing P/E 120.32.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688091.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 688091.SS. This page updates as the calendar is published.
688091.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-12-31 | 0.06135 CNY | n/a | n/a | n/a |
| 2025-09-29 | 0.0616 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.1175 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.07 CNY | n/a | n/a | n/a |
| 2024-10-28 | 0.00079 CNY | n/a | n/a | n/a |
688091.SS valuation and analyst view
| Trailing P/E | 120.32 |
|---|---|
| Trailing EPS | 0.33259 CNY |
| Price / book | 5.58 |
| Dividend yield | 0.00% |
| Market cap | 8.25B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Shanghai Yizhong Pharmaceutical (688091.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 688091.SS. This page updates as the calendar is published.
Did 688091.SS beat earnings last quarter?
Consensus estimate data was not available for 688091.SS's 2025-12-31 report.
What is 688091.SS's current P/E ratio and EPS?
688091.SS trades at a trailing P/E of 120.32 on trailing EPS of 0.33258783071443054 CNY.
What do analysts rate 688091.SS?
688091.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.